Evidence map›Paper›PMID 33593833›Full record

ArticleAntimicrobial agents and chemotherapy2023

Identification and characterization of two novel IS

Ling Li, Mengge Zhang, Wenjia Wang, Ruirui Xia, Yanan Ma, Xin Wei, Xinhua Wang, Xiaomin Sun, Xiaohong Xie, Shiling Xie and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Two novel trimethoprim resistance genes,Antimicrobial agents and chemotherapy · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ling LiState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China.
Mengge ZhangState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China.
Wenjia WangState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China.
Ruirui XiaState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China.
Yanan MaState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China.
Xin WeiState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China.
Xinhua WangShandong Provincial Key Laboratory of Water Pollution Control and Resource Reuse, School of Environmental Science and Engineering, Shandong University, Qingdao, Shandong, China.
Xiaomin SunEnvironmental Research Institute, Shandong University, Qingdao, Shandong, China.
Xiaohong XieShandong Shtars Medical Technology Co., Ltd.
Shiling XieShandong Shtars Medical Technology Co., Ltd.
Mingyu WangState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China. wangmingyu@sdu.edu.cn haixu@sdu.edu.cn.ORCID https://orcid.org/0000-0003-1215-9556
Hai XuState Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China. wangmingyu@sdu.edu.cn haixu@sdu.edu.cn.ORCID https://orcid.org/0000-0001-8710-3026

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two novel IS

Identifiers

PMID33593833
PMCPMC8092886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.